The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma
Song Han,David Hernandez Gonzalo,Michael Feely,Daniel Delitto,Kevin E. Behrns,Mark Beveridge,Dongyu Zhang,Ryan M. Thomas,Jose G. Trevino,Thomas D. Schmittgen,Steven J. Hughes +10 more
Reads0
Chats0
TLDR
Data suggest interactions within the tumor microenvironment alter miRNA expression, which in turn have a functional impact on TAS, as well as regulation of mi RNA expression by cell-cell contact.Abstract:
The pancreatic adenocarcinoma (PDAC) microenvironment is largely comprised of fibrotic tumor associated stroma (TAS) that contributes to the lethal biology of PDAC. microRNA (miRNA) are small non-coding RNAs that regulate gene expression. We hypothesized that interactions between PDAC cells and TAS cells within the microenvironment modulate miRNA expression and thus, tumor biology. We observed that miR-205 and members of the miR-200 family (miR-200a, -200b, -200c, -141 and miR-429) were exclusively expressed in PDAC cells, consistent with an epithelial miRNA signature, while miR-145 and miR-199 family members (miR-199a and -199b) were solely expressed in TAS cells, consistent with a stromal miRNA signature. This finding was confirmed by qRT-PCR of RNA obtained by laser-capture microdissection of surgical specimens. Using an in vitro co-culture model, we further demonstrated regulation of miRNA expression by cell-cell contact. Forced expression in TAS cells of miR-200b/-200c and miR-205 to mimic these observed changes in miRNA concentrations induced secretion of GM-CSF and IP10, and notably inhibited migration. These data suggest interactions within the tumor microenvironment alter miRNA expression, which in turn have a functional impact on TAS.read more
Citations
More filters
Journal ArticleDOI
The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma
TL;DR: The recent advances regarding new functions of activated PSCs, including P SCs-cancer cells interaction, mechanisms involved in immunosuppressive regulation, and metabolic reprogramming are discussed.
Journal ArticleDOI
MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1
Yangyang Zhan,Nanxin Zheng,Fei Teng,Bao Leilei,Fang Liu,Mingjian Zhang,Meng Guo,Wen-yuan Guo,Guoshan Ding,Quanxing Wang +9 more
TL;DR: Results indicate that miR-199a/b acts as tumor suppressors in HCC and represent promising therapeutic targets.
Journal ArticleDOI
Stroma-derived extracellular vesicles deliver tumor-suppressive miRNAs to pancreatic cancer cells.
Song Han,David Hernandez Gonzalo,Michael Feely,Carlos Rinaldi,Sayali Belsare,Haiyan Zhai,Krishan Kalra,Michael H. Gerber,Chris E. Forsmark,Steven J. Hughes +9 more
TL;DR: It is highlighted that TAS cells secrete exosomes carrying tumor suppressive genetic materials, a possible anti-tumor capacity, and future work of the development of patient-derived exosome could have therapeutic implications for unresectable PDAC.
Journal ArticleDOI
The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
Gargi Maity,Inamul Haque,Arnab Ghosh,Arnab Ghosh,Gopal Dhar,Vijayalaxmi Gupta,Sandipto Sarkar,Sandipto Sarkar,Imaan Azeem,Douglas H. McGregor,Abhishek Choudhary,Donald R. Campbell,Donald R. Campbell,Suman Kambhampati,Sushanta K. Banerjee,Sushanta K. Banerjee,Snigdha Banerjee +16 more
TL;DR: Evidence is presented that MAZ mRNA expression and protein levels are increased in human PDAC cell lines, tissue samples, a subcutaneous tumor xenograft in a nude mouse model, and spontaneous cancer in the genetically engineered PDAC mouse model and it is proposed that Cyr61/CCN1-induced expression of MAZ promotes invasive phenotypes of PDAC cells not through direct K-Ras activation but instead through the activation of CRAF–ERK signaling.
Journal ArticleDOI
microRNA-based diagnostic and therapeutic applications in cancer medicine
TL;DR: A review of microRNA-based clinical applications can be found in this article, where the authors highlight the most promising approaches and standing challenges to translate these findings into viable microRNAbased clinical tools for cancer medicine.
References
More filters
Journal ArticleDOI
Cancer statistics, 2016
TL;DR: Overall cancer incidence trends are stable in women, but declining by 3.1% per year in men, much of which is because of recent rapid declines in prostate cancer diagnoses, and brain cancer has surpassed leukemia as the leading cause of cancer death among children and adolescents.
Journal ArticleDOI
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
Philip A. Gregory,Andrew G. Bert,Emily L. Paterson,Simon C. Barry,Anna Tsykin,Gelareh Farshid,Mathew A. Vadas,Mathew A. Vadas,Yeesim Khew-Goodall,Gregory J. Goodall +9 more
TL;DR: It is found that all five members of the microRNA-200 family were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-β or to ectopic expression of the protein tyrosine phosphatase Pez, suggesting that downregulation of themicroRNAs may be an important step in tumour progression.
Journal ArticleDOI
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
TL;DR: In this article, the miR-200 miRNA family was found to directly target the mRNA of the E-cadherin transcriptional repressors ZEB1 (TCF8/δEF1) and ZEB2 (SMAD-interacting protein 1 [SIP1]/ZFXH1B).
Journal ArticleDOI
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma
Andrew D. Rhim,Andrew D. Rhim,Paul E. Oberstein,Dafydd H. Thomas,Emily T. Mirek,Carmine F. Palermo,Stephen A. Sastra,Erin N. Dekleva,Tyler Saunders,Claudia P. Becerra,Ian W. Tattersall,C. Benedikt Westphalen,Jan Kitajewski,Maite G. Fernandez-Barrena,Martin E. Fernandez-Zapico,Christine A. Iacobuzio-Donahue,Kenneth P. Olive,Ben Z. Stanger +17 more
TL;DR: De deleting Shh in a well-defined mouse model of PDAC demonstrated that some components of the tumor stroma can act to restrain tumor growth, and administration of VEGFR blocking antibody selectively improved survival of Shh-deficient tumors.
Journal ArticleDOI
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
TL;DR: Loss of expression of the miR-200 family members may play a critical role in the repression of E-cadherin by ZEB1 and ZEB2 during EMT, thereby enhancing migration and invasion during cancer progression.
Related Papers (5)
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Adam E Frampton,Leandro Castellano,Teresa Colombo,Elisa Giovannetti,Jonathan Krell,Jimmy Jacob,Loredana Pellegrino,Laura Roca-Alonso,Niccola Funel,Tamara Gall,Alexander de Giorgio,Filipa G. Pinho,Valerio Fulci,David Britton,Raida Ahmad,Nagy A. Habib,R. Charles Coombes,Victoria Harding,Thomas Knösel,Justin Stebbing,Long R. Jiao +20 more